IRIS UniCatt

Ruggeri, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.171
NA - Nord America 2.785
AS - Asia 1.706
SA - Sud America 371
AF - Africa 37
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 8.088
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.724
IT - Italia 1.229
SG - Singapore 806
DE - Germania 642
CN - Cina 503
SE - Svezia 335
BR - Brasile 312
UA - Ucraina 269
FR - Francia 158
GB - Regno Unito 119
IE - Irlanda 116
ID - Indonesia 72
FI - Finlandia 68
IN - India 68
VN - Vietnam 61
RU - Federazione Russa 58
TR - Turchia 47
CA - Canada 40
ES - Italia 31
NL - Olanda 30
BE - Belgio 25
BD - Bangladesh 24
CH - Svizzera 22
AR - Argentina 20
HK - Hong Kong 19
PL - Polonia 18
IQ - Iraq 15
IR - Iran 15
JP - Giappone 15
EC - Ecuador 13
ZA - Sudafrica 12
VE - Venezuela 10
KR - Corea 9
MX - Messico 9
AT - Austria 7
AU - Australia 7
PK - Pakistan 7
RO - Romania 7
JO - Giordania 6
KZ - Kazakistan 6
TN - Tunisia 6
ET - Etiopia 5
EU - Europa 5
HR - Croazia 5
UZ - Uzbekistan 5
CL - Cile 4
CO - Colombia 4
CZ - Repubblica Ceca 4
GR - Grecia 4
KW - Kuwait 4
LB - Libano 4
LT - Lituania 4
MA - Marocco 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
EE - Estonia 3
HN - Honduras 3
KE - Kenya 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PT - Portogallo 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
BY - Bielorussia 2
CR - Costa Rica 2
EG - Egitto 2
IL - Israele 2
JM - Giamaica 2
MD - Moldavia 2
MZ - Mozambico 2
PY - Paraguay 2
AL - Albania 1
AQ - Antartide 1
BB - Barbados 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
ME - Montenegro 1
ML - Mali 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PG - Papua Nuova Guinea 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 8.088
Salva come PNG Salva come JPEG
Città #
Chandler 434
Singapore 283
Ashburn 192
Jacksonville 190
Milan 169
Ann Arbor 147
Plan 117
Dublin 114
San Mateo 112
Beijing 111
Cattolica 110
Nanjing 92
Rome 82
Woodbridge 76
Wilmington 68
Bremen 67
Jakarta 67
Boston 60
Dearborn 59
Munich 59
Lawrence 57
Los Angeles 47
Mountain View 46
Nanchang 42
Marseille 41
Seattle 40
Buffalo 37
Moscow 37
New York 32
São Paulo 32
Houston 28
Redwood City 27
Frattamaggiore 26
Turin 26
Izmir 25
Brussels 23
Ho Chi Minh City 22
Shanghai 22
Frankfurt am Main 20
Boardman 19
Hong Kong 18
Jiaxing 17
Lancaster 17
Redmond 17
Bari 16
Enterprise 16
Hanoi 16
Hebei 16
Kunming 15
Bologna 14
Chicago 14
Fairfield 14
Changsha 13
Hangzhou 13
Norwalk 13
Nürnberg 13
Augusta 12
Detroit 12
Hefei 12
Torino 12
University Park 12
Brooklyn 11
Guangzhou 11
Chennai 10
Falls Church 10
Fremont 10
Princeton 10
Tokyo 10
Brasília 9
Como 9
Kish 9
Kraków 9
Montreal 9
Napoli 9
Ottawa 9
Paris 9
Rio de Janeiro 9
Tianjin 9
Düsseldorf 8
London 8
Mumbai 8
Pune 8
Taranto 8
Toronto 8
Dallas 7
Florence 7
Johannesburg 7
Moncalieri 7
Parma 7
Zurich 7
Amman 6
Amsterdam 6
Arzano 6
Atlanta 6
Cambridge 6
Campinas 6
Curitiba 6
Getafe 6
Palermo 6
Poplar 6
Totale 3.872
Salva come PNG Salva come JPEG
Nome #
I costi socio-sanitari dell’insufficienza renale cronica 732
L'analisi dei network organizzativinei sistemi sanitari: il caso della rete di emergenza della Regione Lazio 373
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 206
Economia sanitaria 206
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use 164
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 162
Cost Effectiveness Analysis of Instanyl for the Treatment of Breakthrough Cancer Pain (BtcP) 160
Use of robot-specific resources and operating room times: the case of Telelap Alf-X robotic hysterectomy 155
Il modello WEF per la valutazione economica delle innovazioni terapeutiche in epatologia. 148
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 146
Healthcare expenditure on prevention in the spending review era 141
Money back guarantee? A cost–benefit framework of performance-based agreements (PBAs) for the reimbursement of pharmaceuticals 138
Health Technology Assessment of the anti HCV strategies in Italy: evidences from the WEF Project 137
Investigating the generalizability of Economic Evaluations conducted in Italy: a critical review 134
The harmonic study: cost-effectiveness evaluation of the use of the ultrasonic scalpel in total thyroidectomy 131
Valutazione economica dei programmi di screening contro il cancro del colon retto: evidenze indirette di lungo periodo e sostenibilita` finanziaria in un’ottica di programmazione regionale 128
Economic evaluation of screening programs for HCV: evidence from literature. 123
A pharmacoeconomic analysis of phosphate binders cost-effectiveness in the RISCAVID study. 121
A cost effectiveness analysis of cataract surgery 121
Between rationing and rationalization. The challenges of the Italian National Health Service during the age of the great crisis 120
Budget Impact Analysis of Fingolimod in Relapsing Remitting Multiple Sclerosis 119
Valutazione economica di Teysuno nel trattamento del Carcinoma gastrico avanzato 116
Harmonic study: A cost-effectiveness evaluation of ultrasonically activated shears for total thyroidectomy [Lo studio HARMONIC: Valutazione costo-efficacia dell'uso del bisturi a ultrasuoni negli interventi di tiroidectomia totale] 115
Economic assessment of Eltrombopag in the treatment of thrombocytopenia 115
Activity-based costing analysis of the analgesic treatments used in postoperative pain management in Italy. 115
Economic assessment of Zostavax vaccine for the prevention of Herpes Zoster 114
Cost effectiveness analysis of transnasal fentalyl citrate in the treatment of BTcP 113
Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory. 112
Cohort Of Hcv Patients In Italy: Sizing And Treatments In A Sample Of Italian Hepatology Centers. 110
The cost-effectiveness of alternative strategies against HBV in Italy 108
A new decision model for economic evaluation of novel therapies for HCV 108
Patients Diagnostic Therapeutic Pathways For Hcv Patients In Italy: Impact Of Regionalization In Treatments And Guidelines. 107
Economic Evaluation of 5-Grass Pollen Tablets Versus Placebo in the Treatment of Allergic Rhinitis in Adults 105
L’utilizzo di modelli decisionali per le valutazioni economiche dei farmaci in Italia: stato dell’arte e prospettive future 105
Come comunicare e trasferire i risultati delle valutazioni di HTA applicata alle vaccinazioni ai decision makers e agli stakeholders? il progetto dell’ISPOR Rome chapter 103
Extending influenza vaccination to individuals aged 50–64: A budget impact analysis 102
Do Probability and Certainty Equivalent techniques lead to inconsistent results? Evidence from gambles involving life years and quality of life. 102
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 102
Clinical and economic evaluation of tapentadol ER and oxycodone/naloxone. 101
Valutazione economica della tossina botulinica per la profilassi dell’emicrania cronica 98
The minimum clinically important difference of the EQ-5D index. 98
New Healthcare Professional Roles in Europe: a Survey of Patients' Experiences and Views in Nine Countries 97
Economic Evaluation of the Hepatitis C Virus Treatment Extension to Early-Stage Fibrosis Patients: Evidence from the PITER Real-World Cohort 96
Valutazione economica di ranibizumab vs pegaptanib o vs terapia fotodinamica con verteporfina 95
New professional roles and patient satisfaction: evidence from a European survey along three clinical pathways 95
Lo studio HARMONIC: valutazione costo-efficacia dell’uso del bisturi a ultrasuoni negli interventi di tiroidectomia totale 94
Normative needs in healthcare: toward a new conceptualization of equity and capabilities. 94
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C 93
Cost-effectiveness analysis of two Rituximab retreatment regimens for longstanding rheumatoid arthritis. 93
Economic Assessment of an Anti-HCV Screening Program in Italy 92
THE HARMONIC STUDY: COST-EFFECTIVENESS EVALUATION OF THE USE OF THE ULTRASONIC SCALPEL IN TOTAL THYROIDECTOMY. 91
Evolution of the healthcare expenditure in Italy and effects of fingolimod increased prescribing in second line treatment of relapsing-remitting multiple sclerosis. 91
Economic assessment of Eltrombopag in the treatment of thrombocytopenia 85
Cost effectiveness studies in HIV treatment with Lopinavir/Ritonavir: a Review. 84
Setting research priorities in the feld of emergency management: which piece of information are you willing to pay more? 83
Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort 82
The cost effectiveness of Botox in Italian patients with chronic migraine. 81
Analisi economica per l’estensione della vaccinazione contro l’influenza agli individui di età 50-64: risparmi sociali e analisi di Budget Impact 80
Sevelamer Is Cost-Saving vs. Calcium Carbonate in Non-Dialysis-Dependent CKD Patients in Italy: A Patient-Level Cost-Effectiveness Analysis of the INDEPENDENT Study. 80
Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study. 78
Cost-effectiveness analysis of Daclatasvir/Sofosbuvir for the treatment of the HCV patients failed after the first line with second generation of DAAs in Italy . 77
Introduction to essay health and economics 74
Valutazione dei costi delle infezioni nosocomiali da E.Coli in un policlinico romano di 1700 posti letto 73
Cost effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C. 70
Is risk attitude really specific within the health context domain? Further evidence from an Italian survey using Probability Equivalent technique and face to face interviews 63
Hepatocellular carcinoma: cost-effectiveness of screening. A systematic review 60
Is risk outcome specific within the health domain? 54
Totale 8.169
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.142
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.142
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021351 0 0 0 0 0 16 44 26 145 22 83 15
2021/2022677 58 68 20 27 31 26 54 108 30 43 84 128
2022/20231.319 147 186 96 223 91 170 56 113 163 17 46 11
2023/2024614 36 179 20 38 32 67 20 29 18 26 83 66
2024/20251.061 24 50 105 28 121 29 13 46 207 87 177 174
2025/20261.269 435 85 100 202 420 27 0 0 0 0 0 0
Totale 8.169